| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |